Dh. Berger et al., Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status, CANCER, 85(2), 1999, pp. 326-332
BACKGROUND. Cigarette smoking is among the few unequivocal risk factors for
the development of pancreatic ductal adenocarcinoma (PDAC). Activating mut
ations in codon 12 of the K-ras protooncogene is a frequent and early molec
ular event in the pathogenesis of PDAC and a variety of nonmalignant ductal
pancreatic lesions. The molecular epidemiologic relation between heavy cig
arette smoking and mutational activation of K-ras in PDAC has been examined
to a limited extent. The authors have examined the mutational status of K-
ras in nonneoplastic pancreata in relation to cigarette smoking status.
METHODS. Archival formalin fixed paraffin embedded specimens of nonneoplast
ic pancreata (n = 39) were obtained from the American Cancer Society and ev
aluated histopathologically. Specimens from age- and gender-matched individ
uals were stratified into three groups: 1) those who never smoked cigarette
s (n = 16), 2) those who smoked 1-2 packs/day for more than 20 years (n = 1
0 cases), and 3) those who smoked more than 2 packs/day for 20 or more year
s (n = 13). Cases were preselected from 77 specimens based on the quality,
suitability, and cellularity of the archival tissues for analyses. Furtherm
ore, none of the patients died of primary PDAC or had evidence of pancreati
c metastases from an extrapancreatic primary tumor. Tissue sections were mi
crodissected and deparaffinized, and genomic DNA was purified by standard p
roteinase K-phenol-chloroform extraction techniques. Genomic DNA was analyz
ed for mutations in codon 12 of the K-rns protooncogene by two mutant-allel
e-enriched polymerase chain reaction (PCR)-restriction fragment length poly
morphism (RFLP) assays and by multiplex PCR-based ligase chain reaction (LC
R) analyses.
RESULTS. Analyses of multiple microdissected pancreata specimens from 39 ca
ses revealed wild-type K-ras codon 12 sequences in both nonsmoking individu
als and those who smoked 1-2 packs/day for 20 or more years. R-ms codon 12
mutations were confirmed by PCR-RFLP and PCR-LCR assays in 5 of 13 pancreat
a cases (39%) obtained from individuals who smoked more than 2 packs of cig
arettes/day for 20 years or more (P < 0.005). The K-ras mutation spectra re
vealed two G-->T transversions, one G --> C transversion and two G-->A tran
sitions. There was no clear relation between the incidence or spectra of mu
tations and pancreatic histopathology, as overtly normal pancreata as well
as pancreata with squamous metaplasia, periductal fibrosis, and ductal atyp
ia revealed reproducible K-ms alterations. Similarly, among those 34 cases
in which a wild-type K-rns sequence was revealed by both approaches, a simi
lar histopathologic profile was evident.
CONCLUSIONS. Mutational activation of codon 12 of the K-ms protooncogene wa
s confirmed reproducibly by mutant allele-enriched PCR-RFLP and multiplex P
CR-LCR analyses in 39% (5 of 13) of archival nonneoplastic pancreata from a
ge- and gender-matched individuals who smoked more than 2 packs of cigarett
es/day for 20 or more years. The presence of a mutated or wild-type or K- m
s was independent of the histopathologic profile of the 39 cases examined.
The data provide further suggestive molecular epidemiologic evidence of an
association between a major and unequivocal risk factor for PDAC (heavy cig
arette smoking) and mutations in a molecular target (K-ras), the activation
of which is an important and early event both in the pathogenesis of PDAC
and in the development of a variety of nonneoplastic ductal pancreatic lesi
ons.(C) 1999 American Cancer Society.